Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$5B
sum of reported positions
Reported positions
82
Changes vs prior quarter
61
20 new · 14 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 22 measured positions in 6 quarters, the typical new or larger position finished −1.4 pts against the S&P 500 and 45% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 112M | $1.2B | 23.9% | |
| 4.3M | $735M | 14.7% | |
| 4.72M | $483M | 9.7% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $3.68B | $5B |
| Positions | 76 | 82 |
| Biggest line | — | Lifestance Health 24% |
| 7.89M |
| $322M |
| 6.4% |
| 6.49M | $286M | 5.7% |
| 16.4M | $275M | 5.5% |
| 12.3M | $213M | 4.3% |
| 4.11M | $124M | 2.5% |
| 5.78M | $92.1M | 1.8% |
| 3.01M | $89.4M | 1.8% |
BRUKER CORP | 176K | $78.3M | 1.6% |
| 3.76M | $73.2M | 1.5% |
BOFA FIN LLC | 56.6M | $71.2M | 1.4% |
| 3.69M | $69M | 1.4% |
| 6.88M | $44.9M | 0.9% |
EVERGY INC | 29.8M | $42.3M | 0.8% |
WEC ENERGY GROUP INC | 34M | $42.1M | 0.8% |
NOVANTA INC | 612K | $41.7M | 0.8% |
NEXTERA ENERGY INC | 825K | $39.3M | 0.8% |
| 18.7M | $38.9M | 0.8% |
| 2.05M | $38.3M | 0.8% |
DOORDASH INC | 31M | $30.5M | 0.6% |
HEWLETT PACKARD ENTERPRISE C | 250K | $29.2M | 0.6% |
PG&E CORP | 28.5M | $29.1M | 0.6% |
PG&E CORP | 680K | $28.2M | 0.6% |
ENVIRI CORP
3.61M shares in Q1 2026
CLEARWATER ANALYTICS HLDGS I
385K shares in Q1 2026
ONESTREAM INC
325K shares in Q1 2026
ORACLE CORP
225K shares in Q1 2026
APELLIS PHARMACEUTICALS INC
50K shares in Q1 2026
MASIMO CORP
25K shares in Q1 2026
HAYMAKER ACQUISITION CORP IV
25K shares in Q1 2026
LANVIN GROUP HOLDINGS LIMITE
20K shares in Q1 2026
Silicon Labs (SLAB)
15K shares in Q1 2026
Core Scientific, Inc. (CORZ)
10K shares in Q1 2026
Revolution Medicines (RVMD)
2,500 shares in Q1 2026
